Hostname: page-component-5db58dd55d-h5th4 Total loading time: 0 Render date: 2026-05-25T18:39:27.160Z Has data issue: false hasContentIssue false

Novel connexin 30 and connexin 26 mutational spectrum in patients with progressive sensorineural hearing loss

Published online by Cambridge University Press:  15 June 2012

S Battelino
Affiliation:
Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Slovenia
B Repič Lampret
Affiliation:
Centre for Medical Genetics, University Children's Hospital, University Medical Centre Ljubljana, Slovenia
M Žargi
Affiliation:
Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Slovenia
K Trebušak Podkrajšek*
Affiliation:
Centre for Medical Genetics, University Children's Hospital, University Medical Centre Ljubljana, Slovenia
*
Address for correspondence: Dr Katarina Trebušak Podkrajšek, University Medical Centre Ljubljana, University Children's Hospital, Bohoričeva 20, SI-1252 Ljubljana, Slovenia Fax: +386 1 522 93 57 E-mail: katarina.trebusak@kclj.si

Abstract

Objective:

Mutations in the gap junction protein beta-2 gene (‘GJB2’) are known to be responsible for mild to profound congenital and late-onset hearing loss. This study aimed to investigate the molecular basis of progressive hearing loss compared with non-progressive hearing loss.

Methods:

Following clinical otorhinolaryngological evaluation, a genetic analysis was performed in a cohort of 72 patients with progressive sensorineural hearing loss.

Results:

Pathological genotypes were established in 16 patients (22.2 per cent). Six different gap junction protein beta-2 gene mutations were detected in 15 patients, with the c.35delG mutation responsible for 56 per cent of the mutated alleles. A novel gap junction protein beta-6 gene (‘GJB6’) mutation (p.Met203Val) was observed in one patient with mild progressive hearing loss.

Conclusion:

Analyses of gap junction protein beta-2 and -6 genes revealed that similar pathological genotypes, occurring with similar frequencies, were responsible for progressive hearing loss, compared with reported genotypes for non-progressive hearing loss patients. Thus, genotype cannot be used to differentiate non-progressive from progressive hearing loss cases; in this study, patients both with and without an established pathological genotype had a similar clinical course.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable